Showing results (31-40 of 142) with videos related to

Sort By:
Pageof 15
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 15, 2021
Predictors of sinus rhythm 6 weeks after cardioversion of atrial fibrillation: a pre-planned post hoc analysis of the X-VeRT trialRiccardo Cappato, Michael D Ezekowitz, Stefan H Hohnloser, et al.
The American Journal of Cardiology|April 14, 2009
Combination antiplatelet therapy for secondary stroke prevention: enhanced efficacy or double trouble?M Haris U Usman, Lawrence A Notaro, Rangadham Nagarakanti, et al.
European Heart Journal|March 15, 2013
Betrixaban compared with warfarin in patients with atrial fibrillation: results of a phase 2, randomized, dose-ranging study (Explore-Xa)Stuart J Connolly, John Eikelboom, Paul Dorian, et al.
European Journal of Heart Failure|July 12, 2013
Dabigatran compared with warfarin in patients with atrial fibrillation and symptomatic heart failure: a subgroup analysis of the RE-LY trialJorge Ferreira, Michael D Ezekowitz, Stuart J Connolly, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 28, 2018
Edoxaban therapy increases treatment satisfaction and reduces utilization of healthcare resources: an analysis from the EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of atrial fibrillation (ENSURE-AF) studyAndreas Goette, Winghan J Kwong, Michael D Ezekowitz, et al.
Thrombosis and Haemostasis|May 15, 2002
Cholesterol-induced thrombogenicity of the vessel wall: inhibitory effect of fluvastatinMarina Camera, Vincenzo Toschi, Carmen Comparato, et al.
Heart Rhythm|June 25, 2011
Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: a subgroup analysis of TRENDSEmile G Daoud, Taya V Glotzer, D George Wyse, et al.
The American Journal of Cardiology|August 19, 2015
Comparison of Characteristics and Outcomes of Dabigatran Versus Warfarin in Hypertensive Patients With Atrial Fibrillation (from the RE-LY Trial)Rangadham Nagarakanti, Lars Wallentin, Herbert Noack, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|May 26, 2021
Testing the feasibility of operationalizing a prospective, randomized trial with remote cardiac safety EKG monitoring during a pandemicHans H Liu, Michael D Ezekowitz, Michele Columbo, et al.
The American Journal of Cardiology|June 24, 2021
Comparison of Low-Dose Direct Acting Anticoagulant and Warfarin in patients Aged ≥80 years With Atrial FibrillationUsman A Chaudhry, Michael D Ezekowitz, Edward J Gracely, et al.
Pageof 15